NIKKEI 225
37,156.78 -922.92 (-2.42%) HANG SENG
16,180.72 -205.15 (-1.25%) CRUDE OIL
85.04 +2.31 (+2.79%) GOLD FUTURES
2,404.50 +6.50 (+0.27%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
49,772.27 -148.50 (-0.30%)
Ekso Bionics Holdings, Inc. (0IFR.L)
| Previous close | 1.2700 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,151 |
| Market cap | 851,788 |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9260 |
| Earnings date | 25 Apr 2024 - 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireEkso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Pricing, Data Analysis, and Coding (“PDAC”) contractor for the Centers for Medicare & Medicaid Services (“CMS”) has determined a final payment level of $91,031.93 for Medicare reimbursement of the Ekso Indego Personal, which took effect on April 1, 2024. As previou
Simply Wall St.Ekso Bionics Holdings Full Year 2023 Earnings: EPS Misses Expectations
Ekso Bionics Holdings ( NASDAQ:EKSO ) Full Year 2023 Results Key Financial Results Revenue: US$18.3m (up 42% from FY...
Insider MonkeyEkso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Call Transcript March 4, 2024 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.11. EKSO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and […]
